Spain
Loop Dx is a pioneering Health Care startup based in Spain focused on creating innovative diagnostics to enhance early-stage sepsis detection. Founded in 2018, the company has developed the SeptiLoop, a CE IVDR Class C near-patient test, which leverages cell-mediated immune response diagnostics for timely sepsis treatment. This tool measures the functional response of a patient's innate immune system, providing critical data that allows clinicians to administer more targeted treatments well ahead of traditional methods.
Positioned strategically in the European market, SeptiLoop is one of the first new-generation in vitro diagnostic (IVD) tests approved under the IVDR Class C framework. The company is set to roll out commercially in the United Kingdom and the European Union, alongside conducting health economic validation and clinical utility studies in high-risk patient cohorts.
Loop Dx most recently secured a $30.00K Seed Round investment on 15 September 2020 from Health Wildcatters, indicating a promising investment landscape and the potential for impactful growth.
